Official Biochemical and Statistical Evidence 100% Confirms: Moderna Created Covid-19
Evidence has emerged which proves beyond a reasonable doubt that the pharmaceutical giant Moderna, also created the virus in order to sell and make a gazillion dollar fortune off our misery!
Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender
This is a report from a concerned scientist, published exclusively on the Daily Expose.
“They cited a Paper by Scientists in India, Switzerland, Italy and the US (cautiously entitled: MSH3 Homology and Potential Recombination Link to SARS-CoV-2 Furin Cleavage Site) in which they calculated that the chances of a 19 nucleotide sequence patented by Moderna randomly appearing in Covid-19 in circumstances where it does not appear anywhere else in nature are 1 in 3 trillion.
But they failed to make the obvious deduction there from. Had they made said obvious deduction I fear that might have been the last scientific deduction they ever got published!
They decided to investigate the RNA sequence for the Furin cleavage site in the Covid-19 Spike Protein to see if it occurred anywhere else in nature. .
Fortunately the NCBI/NIH have produced the wonderful BLAST database which catalogues every gene sequence in nature known to man and every synthetic patented gene sequence known to the patent office.
The researchers chose the Furin Cleavage sequence because it is the only continuous gene letter sequence (nucleotide sequence) in Covid-19 with more than 3 nucleotides, that differs from the respective letters in its closest natural relative the Bat Coronavirus RaTG13 (all other differences are 3 letters or less long). So it was by far the best candidate for determining whether or not Covid-19 was man made.
Furthermore the Furin Cleavage Site is key to the pathogenicity of Covid-19. So if there was to be some man made gain of function included in the virus, this is where one might expect to find it.
The Amino Acid sequence of the Furin Cleavage Site is PRRA (Proline Argenine Argenine Alanine). Each Amino Acid is coded for by a Codon, consisting of 3 nucleotides (genetic sequence letters). So all the differences in the genetic code between Covid-19 and RaTG13 are at most one Codon long, one amino acid long, other than the Furin Cleavage Sequence, which is…
CCT CGG CGG GCA
The complimentary sequence (the opposing DNA strand of the double helix is (GGAGCCGCCCGT) because C binds with G and A binds with T
The reverse compliment (the same thing written backwards) is therefore TGCCCGCCGAGG
The researchers did a BLAST (Basic Local Alignment Search Tool) alignment search (which means they search for the gene sequence, the reverse gene sequence, the complimentary gene sequence and the reverse complimentary gene sequence) through every gene sequence in nature known to man for CTCCTCGGCGGGCACGTAG which is the 19 nucleotide sequence containing the Furin Cleavage Sequence, which also appears in Covid-19, and which is found actually in the reverse compliment form CTACGTGCCCGCCGAGGAG patented by Moderna.”
Table 1 shows that it does exist in the 5 US patents cited below…
US9149506B2: Modified polynucleotides encoding septin-4 – https://patents.google.com/patent/US9149506B2/en
Inventor: Tirtha Chakraborty, Antonin de Fougerolles
Current Assignee: ModernaTx Inc
2012-04-02 Priority to US201261618953P
2013-12-16 Application filed by Moderna Therapeutics Inc
2014-05-22 Publication of US20140141067A1
2015-10-06 Publication of US9149506B2
2015-10-06 Application granted
2020-01-10 First worldwide family litigation filed
US9216205B2: Modified polynucleotides encoding granulysin – https://patents.google.com/patent/US9216205B2/en
Inventor: Tirtha Chakraborty, Antonin de Fougerolles
Current Assignee: ModernaTx Inc
2012-04-02 Priority to US201261618873P
2013-12-16 Application filed by Moderna Therapeutics Inc
2014-04-24 Publication of US20140113960A1
2015-12-22 Publication of US9216205B2
2015-12-22 Application granted
US9255129B2: Modified polynucleotides encoding SIAH E3 ubiquitin protein ligase 1 – https://patents.google.com/patent/US9255129B2/en
Inventor: Tirtha Chakraborty, Antonin de Fougerolles
Current Assignee: ModernaTx Inc
2012-04-02 Priority to US201261618868P
2013-12-16 Application filed by Moderna Therapeutics Inc
2014-05-22 Publication of US20140141068A1
2016-02-09 Application granted
2016-02-09 Publication of US9255129B2
US9301993B2: Modified polynucleotides encoding apoptosis inducing factor 1 – https://patents.google.com/patent/US9301993B2/en
Inventor: Tirtha Chakraborty, Antonin de Fougerolles
Current Assignee: ModernaTx Inc
2012-04-02 Priority to US201261618957P
2013-12-16 Application filed by Moderna Therapeutics Inc
2014-04-17 Publication of US20140107189A1
2016-04-05 Application granted
2016-04-05 Publication of US9301993B2
2020-01-10 First worldwide family litigation filed
US9587003B2: Modified polynucleotides for the production of oncology-related proteins and peptides – https://patents.google.com/patent/US9587003B2/en
Inventor: Stephane Bancel, Tirtha Chakraborty, Antonin de Fougerolles, Sayda M. Elbashir, Matthias John, Atanu Roy, Susan Whoriskey, Kristy M. Wood, Paul Hatala, Jason P. Schrum, Kenechi Ejebe, Jeff Lynn Ellsworth, Justin Guild
Current Assignee: ModernaTx Inc
2012-04-02 Priority to US201261618868P
2016-02-04 Application filed by ModernaTx Inc
2016-06-02 Publication of US20160152678A1
2017-03-07 Publication of US9587003B2
2017-03-07 Application granted
So Moderna first applied for a patent for the 19 nucleotide sequence in 2013 on December 16.
